drug

(redirected from Disease-modifying antirheumatic drug)
Also found in: Dictionary, Thesaurus, Medical, Legal, Wikipedia.

drug

1. any synthetic, semisynthetic, or natural chemical substance used in the treatment, prevention, or diagnosis of disease, or for other medical reasons
2. a chemical substance, esp a narcotic, taken for the pleasant effects it produces
3. drug on the market a commodity available in excess of the demands of the market

drug

[drəg]
(pharmacology)
Any substance used internally or externally as a medicine for the treatment, cure, or prevention of a disease.
A narcotic preparation.

Drug

principle of evil. [Zoroastrianism: Leach, 325]
See: Evil

Drugs

(dreams)
The interpretation of drugs in your dreams depends on the relationship you have with drugs in your daily life and whether they are doctor prescribed or not. If you are a drug user, then the drugs are an extension of what you normally do, and you need to look at the other details of your dream to get a good interpretation. However, if you use drugs rarely or never, then this dream could represent a need to get well, to escape from daily stress, and a desire to get quick relief. The drugs could be suggesting a need for healing and getting in balance. Your unconscious mind may be suggesting outrageous things in hopes that you get the message to “have fun, dream dreams, and get out of your own head!” Please keep in mind that the purpose of dreams is to raise our consciousness and to assist us in having better lives. The message in the dream about drug use is most likely not encouraging you to use drugs but it may represent a need to feel better or get better.
References in periodicals archive ?
Case 2- A 62-year-old female with RA (Steinbrocker classification: functional class III, stage of disease progression 4) since 1989 was treated with non-biological disease-modifying antirheumatic drugs.
EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs.
In addition, disease-modifying antirheumatic drugs had to have been discontinued for at least 1 month before inclusion.
112), (137) Disease-modifying antirheumatic drugs along with biological agents act by immune system suppression and may be associated with increased susceptibility to infections and cancers.
Part of an extensive Phase 3 program testing baricitinib in more than 3,000 patients at different stages along the RA treatment continuum, the RA-BUILD study enrolled 684 patients with rheumatoid arthritis who previously had an inadequate response to, or were intolerant of, at least one cDMARD and had not received a biologic disease-modifying antirheumatic drug (bDMARD).
Consequently, these two biologic therapies are used typically as first- or second-line biologic treatment after conventional disease-modifying antirheumatic drug (DMARD) therapy failure.
If approved, tofacitinib would be the first RA treatment in a new class of medicines known as JAK inhibitors and the first new oral disease-modifying antirheumatic drug (or DMARD) for RA in more than 10 years.
Moreover, at least one SABER organizer is skeptical about the validity of the study's key conclusion that the serious infection risk in patients started on anti-TNF therapy isn't significantly different than the risk in those started on methotrexate or another nonbiologic disease-modifying antirheumatic drug (DMARD).
Surveyed RA patients most frequently are taking a conventional disease-modifying antirheumatic drug (DMARD) + a TNF-alpha inhibitor, and conventional DMARD monotherapy.
If approved, tofacitinib would be the first RA treatment in a new class of medicines known as Janus kinase (JAK) inhibitors and the first new oral disease-modifying antirheumatic drug (or DMARD) for RA in more than 10 years.
8, had not received prior disease-modifying antirheumatic drug (DMARD) therapy, and had a poor prognosis based on the findings of rheumatoid factor positivity, a positive cyclic citrullinated peptide antibody test, or the presence of at least two erosions.